Methscopolamine Bromide
NDC Package 71406-126-01
Package Information
Methscopolamine Bromide is methscopolamine is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). Marketed by Aace Pharmaceuticals, Inc., this product is identified by NDC 71406-126 and is authorized under FDA application ANDA216786.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71406 - Aace Pharmaceuticals, Inc.
- 71406-126 - Methscopolamine Bromide
- 71406-126-01 - 100 TABLET in 1 BOTTLE
- 71406-126 - Methscopolamine Bromide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71406-126). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71406-126-01 identifies a specific commercial package of 100 tablet in 1 bottle of Methscopolamine Bromide, labeled by Aace Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Aace Pharmaceuticals, Inc. on February 05, 2024. The current certification is valid through April 16, 2024.
What are the primary indications for this medication?
Methscopolamine is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). This medication may help relieve stomach/abdominal pain. However, it has not been shown to be effective in healing these ulcers, preventing them from returning, or preventing other problems caused by ulcers. Methscopolamine works by decreasing the amount of acid in the stomach. It also slows the natural movements of the gut and relaxes the muscles in the stomach/intestines. Methscopolamine belongs to a class of drugs known as anticholinergics.
How is this Aace Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71406012601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.